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Background: Methicillin-resistant staphylococci can colonize and cause diseases in companion animals.
Unfortunately, few molecular studies have been carried out in Brazil and other countries with the aim of
characterizing these isolates. Consequently, little is known about the potential role of companion animals in
transmitting these resistant bacteria to humans. In this work we searched for mecA gene among Staphylococcus
isolates obtained from nasal microbiota of 130 healthy dogs and cats attended in a veterinary clinic located in the
west region of Rio de Janeiro. The isolates recovered were identified to the species level and characterized using
molecular tools.
Results: A community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolate related to USA1100
(Southwest Pacific clone) and susceptible to all non-β-lactams was detected in a cat (1.7%, 1/60). Another
coagulase-positive isolate harboring mecA was recovered from a dog (1.4%, 1/70) and identified as Staphylococcus
pseudintermedius (MRSP) related to the European clone (ST71). The two isolates of Staphylococcus conhii subsp.
urealyticus (1.4%, 1/70 dogs and 1.7%, 1/60 cats), similarly to the MRSP isolate, also presented high-level
multiresistance. The majority of the methicillin-resistant coagulase-negative staphylococci recovered were
Staphylococcus saprophyticus (5.7%, 4/70 dogs and 6.7%, 4/60 cats) and all clustered into the same PFGE type.
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Conclusions: This work demonstrates that mecA-harboring Staphylococcus isolates are common members of the
nasal microbiota of the healthy companion animals studied (9.2%, 12/130 animals), including some high-level
multiresistant isolates of S. pseudintermedius and S. conhii subsp. urealyticus. The detection, for the first time in South
America, of USA1100-related CA-MRSA and of ST71 MRSP (European clone), colonizing companion animals, is of
concern. Both S. pseudintermedius and S. aureus are important agents of infections for animals. The USA1100
CA-MRSA is a causative of severe and disseminated diseases in healthy children and adults. Additionally, MRSP is a
nosocomial pathogen in veterinarian settings. It had already been demonstrated that the virulent ST71 MRSP is
geographically spread over Europe and USA, with potential for zoonotic infections.
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The end of the 1980 decade was marked by the emergency
of community-acquired methicillin-resistant Staphylococcus
aureus (CA-MRSA) among human populations from a
remote area in Australia [1]. The first strain reported was
named Western-Australia 1 (WA-1) and later genotyped as
ST1-SCCmec IV. WA-1 isolates did not frequently carry
the genes lukSF, encoding for the two subunits (S and F) of
the Panton-Valentine leukocidin (PVL) [1,2]. Soon after,
CA-MRSA clones spread over different countries [3]. In the
USA, three main PVL-positive CA-MRSA clones have been
prevailing: USA 300 (ST8-SCCmec IV), USA 400 (ST1-
SCCmec IV) and USA1100 (ST30-SCCmec IV), with USA
300 isolates (ST8-SCCmec IV, PVL+) ranking first among
the causatives of skin/soft skin infections in healthy individ-
uals from the community [4-6]. In Brazil, there are few re-
ports on CA-MRSA infections and most of the isolates are
related to USA 1100, which have been detected causing
infections ranging from simple and localized to severe and
invasive diseases, in previously healthy children and adults
[7]. More recently, MRSA isolates have been found colon-
izing and infecting both companion and livestock animals
with clear economical and public health implications
[8-10]. The detection of MRSA in animals has raised con-
cerns among scientists over their role as potential reser-
voirs or vectors for CA-MRSA infections in humans.
Besides MRSA, other methicillin-resistant staphylococci
(MRS) have recently been detected among companion
animals such as methicillin-resistant Staphylococcus pseu-
dintermedius (MRSP). S. pseudintermedius is a major
cause of purulent and opportunistic infections in dogs,
such as dermatitis, otitis and wound infections. Indeed,
MRSP are frequently multidrug resistant pathogens re-
sembling typical hospital isolates [11,12].
Methicillin-resistant coagulase negative staphylococci
(MRCoNS) have also been isolated in low frequencies
from small companion animals and horses [13,14].
Staphylococcus saprophyticus, for example, is a common
agent of uncomplicated urinary tract infection (UTI) in
young women [15]. Although the report of mecA-harbor-
ing S. saprophyticus is very rare, these isolates haverecently been detected from human patients presented
with UTI [16,17]. Besides, MRCoNS are recognized as op-
portunistic pathogens for immunocompromized patients,
including high-risk human neonates [18]. Of concern is
the fact that MRCoNS are considered a potential reservoir
of resistance determinants, including staphylococcal cas-
sette mec [17]. In the study presented here we searched
for mecA-harboring Staphylococcus isolates in the nasal
microbiota of 130 companion animals attended in a veter-
inary clinic in Rio de Janeiro. The isolates recovered were
identified at subspecies level, and the antimicrobial sus-
ceptibility and genotypic profiles determined.Results and discussion
The mecA gene was confirmed in the 12 staphylococci
that grew in the enrichment broth (9.2%, 12/130 animals).
From these methicillin-resistant streptococci (MRS) iso-
lates 10 were MRCoNS (7.7%, 10/130) and 2 coagulase-
positive MRS (1.5%, 2/130). The majority of MRCoNS
were identified as Staphylococcus saprophyticus (80%, 8/10)
and the remaining as Staphylococcus conhii ssp. urealyticus
(20%, 2/10). One coagulase-positive isolate (BMBSA87),
collected from a cat, harbored mecA and was identified
as MRSA (8.3%, 1/12) and the other isolate (BMBSP02),
obtained from a dog, was initially identified as Staphylococ-
cus intermedius by the automated method (8.3%, 1/12).
Because all dog isolates identified thus far by routine
phenotypic tests as S. intermedius clustered into the newly
identified species S. pseudintermedius [19], additional PCR
identification was carried out yielding an expected single
band of 926 bp, confirming the classification of this isolate
as S. pseudintermedius.
The MRSA isolate was susceptible to all drugs tested
except β-lactams. All isolates identified as S. sapro-
phyticus (except one that was also resistant to rifampi-
cin; 7/8; 87.5%) displayed antimicrobial resistance only
to erythromycin and clindamycin, in addition to β-
lactams. Despite that, the MRSP isolate was resistant to
ciprofloxacin, clindamycin, erythromycin, gentamicin
and trimethoprim sulphamethoxazole, in addition to β-
Figure 1 Pulsed-field gel electrophoresis (PFGE) of the SmaI-
fragmented genomic DNA of the methicillin-resistant
Staphylococcus isolates obtained from nasal swabs of companion
animals. A, lanes 1–4: Representives of the methicillin-resistant
S. saprophyticus ; 5: MRSA from cat (isolate 87); 6: Human isolate of
CA-MRSA belonging to USA 1100 (ST30-SCCmec IV); 7: Lambda-ladder
molecular size marker. B, lane 1: S. pseudintermedius from dog (isolate
02); 2: Representative isolate of the S. conhii-urea (isolate 28) and 3:
Lambda-ladder molecular size marker.
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of S. conhii ssp. urealyticus (Table 1).
The prevalence of MRS among dogs was as follows: 1.4%
(1/70) carried MRSP, 1.4% (1/70) methicillin-resistant S.
conhii-urea (MRSC) and 5.7% (4/70) methicillin-resistant S.
saprophyticus (MRSS), and among cats was: 1.7% (1/60)
carried MRSA, 1.7% (1/60) MRSC and 6.7% (4/60) MRSS.
The MRSA isolate BMBSA87 was typed as SCCmec IV and
displayed a PFGE pattern indistinguishable to that of CA-
MRSA isolate WB49, a representative of the USA1100
clone (ST30-SCCmec IV; Figure 1A, Lanes 5–6), previously
detected in Porto Alegre, RS, Brazil, from human skin/soft
skin infection [20]. In addition, isolate BMBSA87 displayed
the multilocus sequencing type (MLST) allelic profile:
arcc = 2, aroe = 2, glpf = 2, gmk_ = 2, pta_ = 6, tpi_ = 3,
yqil = 2, corresponding to ST30. However, amplification
for the genes lukSF (encoding for PVL) could not be
detected when total DNA of this isolate was tested with
two different, specific, set of primers. PVL is commonly
produced by ST30-SCCmec IV isolates [21,22]. Despite
that, cases of skin/soft tissue infections (SSTI) associ-
ated with PVL-negative CA-MRSA isolates have been
reported [22,23]. In addition, the MRSA isolate detected
in the present study harbored pmsα3 encoding for the
phenol soluble moduline α3, which has been associated
with the pathogenesis of SSTI [24]. Our data showed
that this MRSA isolate also carried the enterotoxin
genes seg, sei, seo of the egc cluster, a highly prevalent
operon of enterotoxin genes. It was suggested that the
apparent redundancy of these superantigens providesTable 1 Species identification and antimicrobial susceptibility
from healthy companion animals
Isolate Species Animal
CEF CIP CLI CLH
BMBSP02 S. pseudintermedius Dog Rb R R R
BMBSA87 S. aureusc Cat R S S S
BMBSC28 S. conhii-uread Cat R S R S
BMBSC30 S. conhii-urea Dog R R R R
BMBSS05 S. saprophyticus Dog R S R S
BMBSS18 S. saprophyticus Cat R S R S
BMBSS21 S. saprophyticus Dog R S R S
BMBSS35 S. saprophyticus Cat R S R S
BMBSS106 S. saprophyticus Cat R S R S
BMBSS110 S. saprophyticus Cat R S R S
BMBSS116 S. saprophyticus Dog R S R S
BMBSS130 S. saprophyticus Dog R S R S
aAntibiograms were carried out as described by the CLSI for the following antimicro
(CHL), erythromycin (ERY), gentamicin (GEN), penicillin G (PEN), rifampicin (RIF), sulf
isolates were susceptible to vancomycin (VAN) when MIC was determined.
bR: resistant and S: susceptible.
cS.aureus: Staphylococcus aureus ssp. aureus.
dS. conhii-urea: S. conhii ssp. urealyticus.selective advantage towards bacterial colonization and/
or spread of the host and not only for toxemia [25]. The
rate of MRSA colonization in dogs (1.4%, 1/70) was
similar to those obtained in other studies (about 1- 2%)
carried out in Hong Kong (2.1%, 15/704) and UK (0.7%,
6/850) [26,27]. Indeed, small number of MRSA wasprofiles of methicillin-resistant Staphylococcus isolated
Antimicrobial susceptibilitya
ERY GEN OXA PEN RIF TEI/ VAN TET TMP
R R R R S S S R
S S R S S S S S
R R R R R S S R
R R R R S S S S
R S R R S S S S
R S R R R S S S
R S R R S S S S
R S R R S S S S
R S R R S S S S
R S R R S S S S
R S R R S S S S
R S R R S S S S
bial drugs: cefoxitin (CEF), ciprofloxin (CIP), clindamycin (CLI), chloramphenicol
amethoxazole-trimethoprim (TMP), teicoplanin (TEC) and tetracycline (TET). All
Figure 2 SCCmec typing of S. saprophyticus isolates. Note that
all isolates amplified with both mecI (A; Lines 1–8) and DCS primers
(B; Lines 2–9). mecA was used as positive control of the PCR
reactions. A; Line 9 and B, Line 1: Low range molecular size marker.
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Brazil (0.9%, 3/348) [13]. This incidence is in accordance
with previous data reporting low percentage (1.2%) of CA-
MRSA carriers among human infant in Brazil [28].
S. pseudintermedius is an important opportunistic patho-
gen of companion animals. It is the most frequent Stap-
hylococcus isolates collected from infected dogs. Since 2006
there has been a significant emergence of MRSP [12].
Many of MRSP isolates from Europe and USA (about 54%)
were classified as ST71-SCCmecII, III or NT (NT:
nontypable) [11,12]. The MRSP recovered here from dog
(isolate BMBSP02) was typed as SCCmec NT. Additionally,
the lambda-ladder molecular size marker was used as ref-
erence to calculate the sizes of the PFGE bands (Figure 1B)
of the isolate BMBSP02. These values were compared with
those obtained from PFGE images of the MRSP isolates
published by Ruscher et al. [12] and Soedarmanto et al.
[29], and it was found that the banding patterns were quite
similar. Thus, MLST analysis was then carried out and
confirmed the presence of this international virulent MRSP
clone (European clone) in our country, since the BMBSP02
clustered into ST71, corresponding to the MLST allelic
profile ack = 3, cpn60 = 9, fdh = 1, pta = 2, sar = 2, tuf = 1.
In Brazil, oxacillin resistance had already been described
among S. pseudintermedius isolates causing urinary tract
infections (8.6%, 6/70 dogs) and external otitis (14.3%, 13/
91 dogs), on the basis of oxacillin 1 μg disk. However, these
isolates were not fully molecular characterized [13,30]. In a
large study, carried out in two distinct localities in South
China, with 785 infected or colonized companion animals
(612 dogs and 173 cats), it was found a total of 8.8% (69/
785) of MRSP, which represented 47.9% (69/144) of the
total S. pseudintermedius isolates [31]. It is impressive the
high level of multiresistance showed by MRSP isolates. In
fact, increased antibiotic resistance has recently been a ten-
dency among MRSP isolates of the international clonal
complex [12] and cross-transmission dog-owner of a
multiresistant MRSP has already been reported [29].
All eight MRSS isolates, from both dogs and cats, clus-
tered into the same PFGE clone type (Figure 1A; lanes 1–
4) and generated amplification products for both DCS and
mecI primers described in 2007 by Milheiriço et al. [32]
(Figure 2). These data indicated that the genes around mec
complex were similar to those of SCCmec II and III (type
II-III). Interestingly, eight MRSS isolates detected in Japan,
which were nontypeable by the current classification for
MRSA or by SCCmec sequencing, had the novel mec type
II-III [16]. Dispite the fact that MRSS isolates were the
most frequent MRS colonizing both cats and dogs in our
study, S. saprophyticus have been isolated in low frequency
from infected cats and dog [33]. It is well known that in
young women, S. saprophyticus is a common agent of
urinary tract infections [15], but still its relative import-
ance is low compared with E. coli [34]. In a studyconducted during one year in Sweden, with women and
men of all ages, growth of S. saprophyticus was a quite un-
common finding [34]. The majority of individuals with S.
saprophyticus were women between 15–29 years old
(63.8%). However it is important to mention that, in this
group, S. saprophyticus constituted 12.5% of all urinary
tract pathogens [34]. It is also of significance that although
still rare, isolates of MRSS have already been reported
infecting humans in few countries as Canada [35], USA
[36], Japan [16], Sweden [17], and also Brazil [37].
The PFGE type of a representative of S. conhii ssp.
urealyticus (S. conhii-urea) is presented in Figure 1B (lane
2). Similarly to the MRSP isolate, S. conhii-urea isolates
could not be typed for SCCmec with the type system used.
Although very rare and generally considered a commensal
bacteria, the presence of mecA has already been described
in S. conhii either from human or animal origins [38].
Conclusions
This work demonstrates that mecA-harboring Staphylo-
coccus isolates are common members of the nasal
microbiota of the companion animals examined. Some
bacterial species recovered are involved not only in ani-
mals but also in human infections. Moreover, the pres-
ence of USA1100-related MRSA colonizing animals is
of concern. ST30 isolates are important CA-MRSA
pathogens worldwide spread that has been associated to
serious invasive diseases in adult and children in this
country [39]. S. pseudintermedius is the most prevalent
pathogenic streptococci in companion animals. To the
best of our knowledge, that is the first report recogniz-
ing the prevalence of the European clone of MRSP
(ST71) and of the USA1100 clone of MRSA (ST30) col-
onizing animals in Brazil. Both CA-MRSA and MRSP
have already been incriminated in potential zoonotic
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portant multidrug-resistant pathogens in animals.
The fact that most of mecA-positive isolates were S.
saprophyticus also poses an important question concerning
potential transfer of MRSS between animals and humans.
Finally, our data indicate that continued surveillance studies
involving fully identification and genotyping of Staphylococ-
cus isolates should be carried out in this and other coun-




Hundred and thirty nasal swabs were obtained from 70
dogs and 60 cats which were visiting a veterinarian clinic,
located in Rio de Janeiro city, RJ, for pet grooming, during
the year of 2010. The animals included in this study were
healthy and free of hospitalization, antimicrobial therapy
and invasive device in the six-month before sample collec-
tions. The swabs were collected from the anterior nares
of the animals, using a transport system (Culture Swab
Transport System; Copan Italia SpA.; Brescia Italy), and
stored at 4°C for no more than 24 h. Written informed
consent for participation was obtained from the owners of
all animals included in the study. The study was approved
(# IMPPG030) by the Animal Ethics Committee from
Centro de Ciências da Saúde, Universidade Federal do Rio
de Janeiro.
Bacterial identification
In the laboratory, the swab was introduced in an enrich-
ment broth constituted of tryptic soy broth (TSB, BD;
Becton, Dickinson and Company, BD; Becton Drive-
Franklin Lakes, NJ, USA) supplemented with 10 μg/mL
methicillin and 7.5% of NaCl [40]. After incubation at 37°C
for 18 h-48 h, aliquots of the turbid cultures were streaked
on mannitol salt agar (BD; Becton, Dickinson and Com-
pany, BD; Becton Drive Franklin Lakes, NJ, USA) and in-
cubated at 37°C for 18 h-24 h. Tube coagulase test was
carried out for Gram-positive and catalase-positive col-
onies. Both coagulase-positive and -negative staphylococci
were identified using Microscan WalkAway 96 SI auto-
mated system (Siemens Healthcare Diagnostic, West Sac-
ramento, CA, USA) using Pos Combo Panel Type 33
(PC33) for bacterial identification and susceptibility tests.
PCR amplification using the set of primers pse-F2 TRGG
CAGTAGGATTCGTTAA and pse-R5 CTTTTGTGCTY
CMTTTTGG was carried out for molecular identification
of S. pseudintermedius, as previously described [41].
Antimicrobial susceptibility testing
Antibiograms were also carried out following the Clinical
Laboratory Standard Institute (CLSI) [42] recommenda-
tions for the following antimicrobial disks: cefoxitin (30 μg;CEF) ciprofloxacin (5 μg; CIP), clindamycin (2 μg; CLI),
chloramphenicol (30 μg; CHL), erythromycin (15 μg; ERY),
gentamicin (10 μg; GEN), penicillin G (10 UI; PEN), rifam-
picin (5 μg; RIF), sulfamethoxazole-trimethoprim (25 μg;
TMP), teicoplanin (30 μg; TEC) and tetracycline (30 μg;
TET). The minimum inhibitory concentration (MIC) was
determined for vancomycin (Sigma-Aldrich, St. Louis, MO,
USA) according to CLSI guidelines [42]. The mecA was
tested by polymerase chain reaction (PCR)-amplification of
an internal fragment of the gene [43]. Staphylococcus aur-
eus ATCC 25923 and S. aureus ATCC 29213 were used for
quality control purposes.
Bacterial genotyping
SCCmec typing was carried out for all isolates using differ-
ent typing systems [32,43-46]. Pulsed-field gel electrophor-
esis (PFGE) of the SmaI-fragmented DNA was carried out
for all isolates recovered, according to Teixeira et al. [47].
Multilocus sequence typing (MLST) was carried out as
recommended for MRSA [48] and S. pseudintermedius
[49] isolates. To assign the sequence types the allele se-
quences were correctly trimmed and submitted to the S.
aureus MLST database (http://www.mlst.net), for the CA-
MRSA BMBSA87, or to the MLST website (http://
pubmlst.org/spseudintermedius/) sited at the University of
Oxford for S. pseudintermedius [50].
Detection of virulence genes
The gene lukF-PV and those encoding for enterotoxins G,
I, N and O of the egc cluster (seg, sei, sen and seo) were
assessed by PCR, as described previously [20]. Additionally,
another set of primers was used to test the genes lukSF-PV
[21]. The pmsα3 was tested with the primers described by
Li et al. [25].
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